AIM ImmunoTech Inc. has announced that it has received a warning notification from NYSE American LLC, indicating noncompliance with the minimum stockholders' equity requirements outlined in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide. As of March 31, 2025, AIM reported a stockholders' deficit of negative $3.9 million, alongside losses in its five most recent fiscal years. The company has until June 11, 2026, to regain compliance, following a previously accepted plan by NYSE American. The letter does not affect AIM's business operations or its trading, which continues under the symbol "AIM" on the NYSE American.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。